Effects of Selective Laser Trabeculoplasty on Aqueous Humor Dynamics
1 other identifier
observational
31
1 country
2
Brief Summary
This study will compare aqueous humor dynamics in adults with primary open angle glaucoma that receive Selective Laser Trabeculoplasty (SLT).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2010
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2010
CompletedFirst Submitted
Initial submission to the registry
April 25, 2011
CompletedFirst Posted
Study publicly available on registry
April 27, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2013
CompletedSeptember 6, 2023
August 1, 2023
3.2 years
April 25, 2011
August 30, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Changes in intraocular pressure (IOP) after Selective Laser Trabeculoplasty (SLT) and changes in outflow facility
This study will compare aqueous humor dynamics (intraocular pressure) in adults with primary open angle glaucoma that receive Selective Laser Trabeculoplasty (SLT).
3 years
Eligibility Criteria
Subjects with open angle glaucoma
You may qualify if:
- years of age and older
- Eye consideration for SLT (intraocular pressure above target with current medications, intolerance/allergy to topical medications, patient preference as primary treatment)
- Open angles on gonioscopy
You may not qualify if:
- Any previous surgical or laser procedures
- Secondary glaucoma including pigmentary, exfoliative, uveitic, and traumatic glaucomas
- Corneal opacities interfering with adequate fluorophotometry
- Any active ocular infection within the past 2 months
- Any corneal pathology increasing the likelihood of corneal abrasions
- Inability to safely washout medications prior to laser treatment
- Allergies to fluorescein, timolol, dorzolamide, or sulfa
- Excessive (3+) trabecular meshwork pigmentation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
University of Nebraska Medical Center, Department of Ophthalmology
Omaha, Nebraska, 68198-5540, United States
University of Nebraska Medical Center, Department of Ophthalmology
Omaha, Nebraska, 68198, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vikas Gulati, MD
University of Nebraska
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 25, 2011
First Posted
April 27, 2011
Study Start
September 1, 2010
Primary Completion
November 1, 2013
Study Completion
November 1, 2013
Last Updated
September 6, 2023
Record last verified: 2023-08